HK inno.N Corporation
195940 | KO
Overview
Corporate Details
- ISIN(s):
- KR7195940002
- LEI:
- Country:
- South Korea
- Address:
- 충청북도 청주시 흥덕구 오송읍 오송생명2로 239 에이치케이이노엔(주) 오송공장, 청주시
- Website:
- https://www.inno-n.com/eng
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1.5 MB | ||
| 2025-07-30 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.6 KB | ||
| 2025-07-30 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.7 KB | ||
| 2025-07-30 00:00 |
Earnings Release
영업(잠정)실적(공정공시)
|
Korean | 14.4 KB | ||
| 2025-07-24 00:00 |
Report Publication Announcement
결산실적공시예고
|
Korean | 4.1 KB | ||
| 2025-06-30 00:00 |
Environmental & Social Information
지속가능경영보고서등관련사항(자율공시)
|
Korean | 10.6 KB | ||
| 2025-06-19 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.6 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.3 MB | ||
| 2025-05-07 00:00 |
Regulatory Filings
투자판단관련주요경영사항(임상시험계획승인신청등결정) (IN-B00009의 제3상 임상시험계획 승인)
|
Korean | 10.7 KB | ||
| 2025-04-30 00:00 |
Regulatory Filings
소속부변경
|
Korean | 3.6 KB | ||
| 2025-04-28 00:00 |
Earnings Release
영업(잠정)실적(공정공시)
|
Korean | 14.4 KB | ||
| 2025-04-28 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.6 KB | ||
| 2025-04-28 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.6 KB | ||
| 2025-04-22 00:00 |
Report Publication Announcement
결산실적공시예고
|
Korean | 4.1 KB | ||
| 2025-03-26 00:00 |
AGM Information
정기주주총회결과
|
Korean | 20.7 KB |
Automate Your Workflow. Get a real-time feed of all HK inno.N Corporation filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for HK inno.N Corporation
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for HK inno.N Corporation via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
A biopharmaceutical company developing vaccines and specialty medicines to prevent and treat disease.
United Kingdom
GSK
United Kingdom
GSK
Develops improved drugs and generics, and licenses proprietary drug formulation technologies.
South Korea
204840
South Korea
204840
Biopharma firm developing novel drugs for cancer and inflammatory diseases using genetics.
Japan
2160
Japan
2160
Integrated pharma CDMO developing Rx/OTC meds, supplements & devices for CEE markets.
Hungary
GWPH
Hungary
GWPH
Clinical-stage biopharma developing inhaled therapies for rare pulmonary hypertension.
United States of America
GOSS
United States of America
GOSS
Develops improved drugs for rare neurological diseases using novel drug delivery technologies.
United States of America
GRCE
United States of America
GRCE
South Korea
005250
Develops personalized nutrition solutions, from prescription injections to supplements & cosmetics.
South Korea
234690
South Korea
234690
Developing an immunotherapy vaccine to prevent recurrence in HER2-positive breast cancer patients.
United States of America
GLSI
United States of America
GLSI